Nuwellis (NUWE) Total Non-Current Liabilities (2015 - 2026)
Nuwellis' (NUWE) quarterly Total Non-Current Liabilities came in at $4.2 million in Q2 2026, up 3.11% on a YoY basis from $4.1 million in Q2 2025, and up 7.07% quarter-over-quarter from $3.9 million in Q1 2026.
Analysis
Nuwellis (NUWE) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Total Non-Current Liabilities for 11 consecutive years, with $4.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Non-Current Liabilities rose 3.11% year-over-year to $4.2 million; the trailing twelve-month figure through Jun 2026 stood at $4.2 million (up 3.11% YoY), and the FY2025 full-year result was $3.1 million, up 8.13% from the prior year.
- Total Non-Current Liabilities grew to $4.2 million in Q2 2026 per NUWE's latest filing, from $3.9 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $5.4 million in Q4 2022 and bottomed at $2.9 million in Q4 2024.
- Historically, Total Non-Current Liabilities has averaged $4.0 million across 5 years, with a median of $4.1 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Total Non-Current Liabilities sank 37.68% in 2025, then surged 31.09% in 2026.
- Over 5 years, Total Non-Current Liabilities stood at $5.4 million in 2022, then tumbled by 31.79% to $3.7 million in 2023, then declined by 22.87% to $2.9 million in 2024, then increased by 8.13% to $3.1 million in 2025, then jumped by 35.79% to $4.2 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $4.2 million, $3.9 million, and $3.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | 4.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.21 Mn |
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | 3.10 Mn |
| Sep 30, 2025 | 3.65 Mn |
| Jun 30, 2025 | 4.08 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 2.87 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 4.44 Mn |
| Mar 31, 2024 | 4.81 Mn |
| Dec 31, 2023 | 3.72 Mn |
| Sep 30, 2023 | 3.59 Mn |
| Jun 30, 2023 | 4.48 Mn |
| Mar 31, 2023 | 4.82 Mn |
| Dec 31, 2022 | 5.45 Mn |
| Sep 30, 2022 | 4.42 Mn |
| Jun 30, 2022 | 4.33 Mn |
| Mar 31, 2022 | 4.32 Mn |
| Dec 31, 2021 | 4.29 Mn |
| Sep 30, 2021 | 3.83 Mn |